Table 3 General characteristics of patients
Characteristics | n= 34 | |
|---|---|---|
Sex | Male, n (%) | 13 (38%) |
Female, n (%) | 21 (62%) | |
Age at exposure (yr) | Mean ± SD | 27 ± 9 |
Age at liver biopsy before treatment (yr) | Mean ± SD | 56 ± 10 |
Age at liver biopsy after treatment (yr) | Mean ± SD | 58 ± 10 |
Route of transmission | Blood transfusion, n (%) | 29 (85%) |
Nosocomial, n (%) | 5 (15%) | |
Duration of HCV exposure (yr) | Mean ± SD | 32 ± 10 |
HCV genotype | Genotype 1, n (%) | 24 (70%)& |
Genotype 2, n (%) | 4 (12%)& | |
Genotype 3, n (%) | 2 (6%) | |
ND, n (%) | 5 (15%) | |
Change in HCV viral load after treatment | Increase 1 log, n (%) | 1 (4%) |
Unchanged*, n (%) | 27 (96%) | |
Body mass index (Kg/m2) | Mean (±SD) | 28 ± 7** |